Cargando…
Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease
The use of statin therapy on the prevention of atherosclerotic cardiovascular disease (ASCVD) is recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA); nevertheless, its validation on primary aldosteronism (PA) patients has not been reported. We investigate...
Autores principales: | Lin, Jui-Hsiang, Lin, Yu-Feng, Wang, Wei-Jie, Lin, Yuh-Feng, Chueh, Shih-Chieh Jeff, Wu, Vin-Cent, Chu, Tzong-Shinn, Wu, Kwan-Dun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262476/ https://www.ncbi.nlm.nih.gov/pubmed/30355992 http://dx.doi.org/10.3390/jcm7110382 |
Ejemplares similares
-
Effects of Statin Use in Advanced Chronic Kidney Disease Patients
por: Huang, Tao-Min, et al.
Publicado: (2018) -
Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
por: Huang, Wei‐Chieh, et al.
Publicado: (2019) -
Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2016) -
Corrigendum: Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2017) -
Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism
por: Chen, Ying-Ying, et al.
Publicado: (2019)